4492 related articles for article (PubMed ID: 24362249)
21. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
Reddy JK; Hashimoto T
Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
[TBL] [Abstract][Full Text] [Related]
22. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes.
Watt MJ; Southgate RJ; Holmes AG; Febbraio MA
J Mol Endocrinol; 2004 Oct; 33(2):533-44. PubMed ID: 15525607
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.
Nagaya T; Tanaka N; Kimura T; Kitabatake H; Fujimori N; Komatsu M; Horiuchi A; Yamaura T; Umemura T; Sano K; Gonzalez FJ; Aoyama T; Tanaka E
BBA Clin; 2015 Jun; 3():168-74. PubMed ID: 26674248
[TBL] [Abstract][Full Text] [Related]
24. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
25. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
Holness MJ; Bulmer K; Smith ND; Sugden MC
Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
[TBL] [Abstract][Full Text] [Related]
26. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
27. Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle.
Palacios-González B; Zarain-Herzberg A; Flores-Galicia I; Noriega LG; Alemán-Escondrillas G; Zariñan T; Ulloa-Aguirre A; Torres N; Tovar AR
Biochim Biophys Acta; 2014 Jan; 1841(1):132-40. PubMed ID: 24013029
[TBL] [Abstract][Full Text] [Related]
28. Enzymatically synthesized glycogen reduces lipid accumulation in diet-induced obese rats.
Furuyashiki T; Ogawa R; Nakayama Y; Honda K; Kamisoyama H; Takata H; Yasuda M; Kuriki T; Ashida H
Nutr Res; 2013 Sep; 33(9):743-52. PubMed ID: 24034574
[TBL] [Abstract][Full Text] [Related]
29. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
[TBL] [Abstract][Full Text] [Related]
31. Adiponectin activates the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes.
Chen H; Zhang L; Li X; Li X; Sun G; Yuan X; Lei L; Liu J; Yin L; Deng Q; Wang J; Liu Z; Yang W; Wang Z; Zhang H; Liu G
J Steroid Biochem Mol Biol; 2013 Nov; 138():445-54. PubMed ID: 23994141
[TBL] [Abstract][Full Text] [Related]
32. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
33. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice.
Harada K; Shen WJ; Patel S; Natu V; Wang J; Osuga J; Ishibashi S; Kraemer FB
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1182-95. PubMed ID: 12954598
[TBL] [Abstract][Full Text] [Related]
34. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
35. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
[TBL] [Abstract][Full Text] [Related]
36. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
[TBL] [Abstract][Full Text] [Related]
37. Emerging role of microRNAs in lipid metabolism.
Yang Z; Cappello T; Wang L
Acta Pharm Sin B; 2015 Mar; 5(2):145-50. PubMed ID: 26579440
[TBL] [Abstract][Full Text] [Related]
38. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response.
Feingold K; Kim MS; Shigenaga J; Moser A; Grunfeld C
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E201-7. PubMed ID: 14701665
[TBL] [Abstract][Full Text] [Related]
39. Early induction of a brown-like phenotype by rosiglitazone in the epicardial adipose tissue of fatty Zucker rats.
Distel E; Penot G; Cadoudal T; Balguy I; Durant S; Benelli C
Biochimie; 2012 Aug; 94(8):1660-7. PubMed ID: 22575275
[TBL] [Abstract][Full Text] [Related]
40. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
Dobrzyń A; Dobrzyń P
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]